Serum (1,3)-Beta-d-Glucan has suboptimal performance for the diagnosis of Pneumocystis jirovecii pneumonia in cancer patients and correlates poorly with respiratory burden as measured by quantitative PCR
Ariel D. Szvalb, Alexandre Malek, Ying Jiang, Micah M. Bhatti, Sebastian Wurster, Dimitrios P. Kontoyiannis
Topics & Concepts
Pneumocystis jiroveciiMedicinePneumoniaPneumocystis pneumoniaRespiratory systemCancerRespiratory diseaseImmunologyInternal medicineLungPneumocystis jirovecii pneumonia detection and treatmentAntifungal resistance and susceptibilityFungal Infections and Studies